InvestorsHub Logo
Followers 184
Posts 21912
Boards Moderated 0
Alias Born 08/14/2011

Re: Awl416 post# 36

Thursday, 01/04/2024 6:59:16 AM

Thursday, January 04, 2024 6:59:16 AM

Post# of 59
Flagship's Pioneering Medicines will be eligible to receive up to $532 million in upfront and milestone payments, along with tiered royalties. MASH is a chronic liver disease with high unmet patient need for which there is currently no treatment. Omega's stock soared 25% premarket.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OMGA News